Wang Lao Ji controversies
Controversies tied to this brand in public sources. A listing is not a finding of fault.
Back to profile2 entries
2017
Final ruling in red-can trade dress dispute grants both parties shared rights
In August 2017, the Supreme People's Court issued a final ruling in the dispute between Guangzhou Pharmaceutical Group and JDB over the trade dress of red-can Wanglaoji, revoking the relevant original-instance judgment and holding that both parties shared the rights to the trade dress at issue. This entry records the litigation dispute and final outcome and does not treat the revoked first-instance infringement finding as the final conclusion.
2017
Marketing claim of extending lifespan by 10% questioned by media and experts
In December 2017, a Guangzhou Pharmaceutical Group executive said at a forum that drinking Wanglaoji could extend lifespan by about 10%, and the brand's Weibo spread the claim, sparking controversy over the basis for the promotion. Media and interviewed experts noted that the cited study involved rats, and animal experiment results cannot be directly presumed to be lifespan-extension effects in humans. The cited reports did not provide a final administrative penalty.